UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it will present new Phase 1 and pre-clinical data on DA-1726, ...

Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...

Dispatch Bio, a biotechnology company developing a universal treatment for solid tumors, today announced preclinical data ...

Experts at the 2025 OCT DACH conference will dive into the potential of the European region amid a shifting clinical trial ...

Data gathered up to day 57 after the second dose indicated that VLA1601 was generally well tolerated and safe across all ...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...

Pociredir Phase 1b PIONEER Trial Data in Sickle Cell Disease to be Presented and Published, Including 12 mg and 20 mg Cohorts ― ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces clinical data for CT0596, an allogeneic BCMA-targeting CAR-T ...

Cellectis announced the acceptance of two abstracts for presentation at the ASH 2025 annual meeting, highlighting significant advancements in their clinical trials. The first abstract presents ...